SynthesisDrug safety2025

Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

Shih-Hao Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.